Cencora Stock News

Walgreens Boots Alliance has sold shares of AmerisourceBergen for initial proceeds of $2.85 billion, which will be used to accelerate the drugstore giant's healthcare strategy.

Walgreens Boots Alliance has sold some AmerisourceBergen Corp's shares for proceeds of about $1.85 billion, the U.S. drugstore chain said on Thursday, further cutting its ownership in the drug distributor to about 16%.

Drugstore chain Walgreens Boots Alliance Inc. WBA, -1.17% on Thursday said it sold shares of drug distributor AmerisourceBergen Corp. ABC, -0.04% for initial proceeds of $1.85 billion. Walgreens said it planned to use the proceeds it got from the deal largely to pay down debt and to handle general operations.

AmerisourceBergen Corporation (NYSE:ABC ) Q3 2023 Earnings Call Transcript August 2, 2023 8:30 AM ET Company Participants Bennett Murphy - SVP, Head of IR and Treasury Steve Collis - Chairman, President and CEO Jim Cleary - EVP and CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Lisa Gill - JP Morgan Eric Percher - Nephron Research Daniel Grosslight - Citi Charles Rhyee - TD ...

Drug distributor AmerisourceBergen raised its full-year profit forecast on Wednesday, as soaring demand for weight-loss drugs and specialty medicines helped soften the blow from a fall in COVID-related drug sales in the third quarter.

AmerisourceBergen has seen a 3x return on investment in the past 3 years, outperforming the market. I think it's a very solid company in pharma and healthcare distribution. Investing in high-quality companies when they are cheap is crucial for maximizing returns. AmerisourceBergen is a conservative and safe option in the pharma and healthcare industry, but has now reached a valuation of where I...

Walgreens Boots Alliance has sold shares of AmerisourceBergen for proceeds of $694 million, which will be used "primarily for debt paydown and general corporate purposes."

Asset management firm TPG Inc. TPG, +3.12% and pharmaceutical services company AmerisourceBergen Corp. ABC, -1.75% announced Thursday an agreement to buy oncology practices network OneOncology from private equity firm General Atlantic in a deal that values OneOncology at $2.1 billion. After the deal closes, which is expected to occur by the end of September 2023, TPG will own a majority of OneO...